/TDOC

TDOC Stock - Teladoc Health, Inc.

Q: What is the analyst price target for TDOC?

Analyst price target information is not currently available for TDOC.

Q: What is TDOC's market cap?

Market capitalization information is not currently available for TDOC.

Healthcare|Medical - Healthcare Information Services|NYSE

$6.99-3.59%

$0.26 (-3.59%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+21.6%upside

Target: $8.50

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for TDOC

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.05

52W High$15.21

52W Low$6.35

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$2.57B	$2.60B	$2.41B	$2.03B	$1.09B
Gross Profit	$1.82B	$1.84B	$1.66B	$1.38B	$703.13M
Gross Margin	70.8%	70.8%	69.1%	68.0%	64.3%
Operating Income	$-1,020,886,000	$-248,553,000	$-13,653,214,000	$-265,630,999	$-506,421,000
Net Income	$-1,001,245,000	$-220,368,000	$-13,659,531,000	$-428,793,000	$-485,136,000
Net Margin	-39.0%	-8.5%	-567.5%	-21.1%	-44.3%
EPS	$-5.87	$-1.36	$-84.60	$-2.73	$-5.36

Company Overview

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

Visit Website

Earnings History & Surprises

TDOC

Beat Rate

83%

Last 18 quarters

Avg Surprise

+18.5%

EPS vs Estimate

Beats / Misses

15/3

Last 12 quarters

Latest EPS

$-0.21

Q4 2025

EPS Surprise History

Q1 24

+22.7%

$-0.17vs$-0.22

Q2 24

-4.3%

$-0.49vs$-0.47

Q3 24

+22.2%

$-0.28vs$-0.36

Q4 24

+34.5%

$-0.19vs$-0.29

Q1 25

-33.3%

$-0.28vs$-0.21

Q2 25

+42.4%

$-0.19vs$-0.33

Q3 25

+29.6%

$-0.19vs$-0.27

Q4 25

+19.2%

$-0.21vs$-0.26

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	Apr 28, 2026	—	—	—	—
Q1 2026	Feb 25, 2026	$-0.19	—	—	—
Q4 2025	Oct 29, 2025	$-0.26	$-0.21	+19.2%	✓ BEAT
Q3 2025	Jul 29, 2025	$-0.27	$-0.19	+29.6%	✓ BEAT
Q2 2025	Apr 30, 2025	$-0.33	$-0.19	+42.4%	✓ BEAT
Q1 2025	Feb 26, 2025	$-0.21	$-0.28	-33.3%	✗ MISS
Q4 2024	Oct 30, 2024	$-0.29	$-0.19	+34.5%	✓ BEAT
Q3 2024	Jul 31, 2024	$-0.36	$-0.28	+22.2%	✓ BEAT
Q2 2024	Apr 25, 2024	$-0.47	$-0.49	-4.3%	✗ MISS
Q1 2024	Feb 20, 2024	$-0.22	$-0.17	+22.7%	✓ BEAT
Q4 2023	Oct 24, 2023	$-0.37	$-0.35	+5.4%	✓ BEAT
Q3 2023	Jul 25, 2023	$-0.44	$-0.40	+9.1%	✓ BEAT
Q2 2023	Apr 26, 2023	$-0.51	$-0.37	+27.5%	✓ BEAT
Q1 2023	Feb 22, 2023	$-0.27	$-0.23	+14.8%	✓ BEAT
Q4 2022	Oct 26, 2022	$-0.59	$-0.45	+23.7%	✓ BEAT
Q3 2022	Jul 27, 2022	$-0.71	$-0.44	+38.0%	✓ BEAT
Q2 2022	Apr 27, 2022	$-0.55	$-0.47	+14.5%	✓ BEAT
Q1 2022	Feb 22, 2022	$-0.59	$-0.07	+88.1%	✓ BEAT
Q4 2021	Oct 27, 2021	$-0.70	$-0.53	+24.3%	✓ BEAT
Q3 2021	Jul 27, 2021	$-0.59	$-0.86	-45.8%	✗ MISS

Frequently Asked Questions about TDOC

What is TDOC's current stock price?

Teladoc Health, Inc. (TDOC) is currently trading at $6.99 per share. The stock has moved -3.59% today.

What is the analyst price target for TDOC?

The average analyst price target for TDOC is $8.50, based on 1 analyst.

What sector is Teladoc Health, Inc. in?

Teladoc Health, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NYSE exchange.

What is TDOC's market cap?

Teladoc Health, Inc. has a market capitalization of $1.24 billion, making it a small-cap company.

Does TDOC pay dividends?

No, Teladoc Health, Inc. does not currently pay a dividend to shareholders.